Cleared Traditional

K092125 - PRESIDIO PACS

K092125 is an FDA 510(k) clearance for PRESIDIO PACS, manufactured by Reaonix Security, LLC. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 148-day FDA review.

K092125 · Reaonix Security, LLC · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2009
Decision
148d
Days
Class 2
Risk

K092125 is an FDA 510(k) clearance for the PRESIDIO PACS. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Reaonix Security, LLC (Buford, US). The FDA issued a Cleared decision on December 10, 2009 after a review of 148 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Reaonix Security, LLC devices

FDA 510(k) Submission Details - K092125

510(k) Number K092125 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 15, 2009
Decision Date December 10, 2009
Days to Decision 148 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
41d slower than avg
Panel avg: 107d · This submission: 148d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1321
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K092125.
PCR ELEVA 1.2
K093355 · Philips Medical Systems, Inc. · Jan 2010
XELERIS 3 PROCESSING AND REVIEW WORKSTATION
K093982 · Ge Medical Systems F.I. Haifa · Jan 2010
DIGITAL LIGHTBOX
K093117 · Brainlab AG · Dec 2009
INNOVA VISION, MODEL S18751VN, INNOVA TRACKVISION, MODEL S18751VT, INNOVA EPVISION, MODEL S18751EP
K092639 · GE Medical Systems SCS · Dec 2009
COLOR LCD MONITOR, MODEL RADIFORCE MX241W
K092741 · Eizo Nanao Corporation · Nov 2009
INTEGRATED REGISTRATION
K093234 · GE Medical Systems SCS · Oct 2009